FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2792922144> ?p ?o ?g. }

• W2792922144 abstract "Guidelines support the use of neoadjuvant (NAC) and adjuvant (AC) chemotherapy in muscle-invasive bladder cancer. However, data from North America reported the underutilization of NAC in favor of AC despite the lower level of scientific evidence supporting AC. We aimed to assess current practice patterns of NAC and AC in -Germany.A 15-question online survey was developed and sent via email newsletters to members of the -German Association of Urology and of the German Society of Residents in Urology in October 2016 to analyze current practice patterns.The survey yielded 141 individual responses from 61 different German urology departments. Eighty-nine (69.0%) and 119 (93.0%) participants were stated to regularly use NAC and AC respectively. The number of participants who were stated to use NAC and AC regularly was not associated with the type of institution (academic vs. nonacademic), number of hospital beds, and number of cystectomies performed annually. Gemcitabine/cisplatin combination chemotherapy was named as the primarily used NAC regimen by 80 (95%) respondents. The median number of administered cycles was 3 for NAC and 4 for AC. In the case of cisplatin ineligibility, combination chemotherapy with gemcitabine/carboplatin was the most common regimen. Respondents stated that chemotherapy was generally administered by urologists (81% for NAC and 85% for AC).Our survey of current practice shows a high acceptance rate of NAC in Germany, which was independent of the type of institution. Although the scientific level of evidence for AC is lower, it still seems to be more widely accepted than NAC. NAC and AC were generally administered by urologists." @default.
• W2792922144 created "2018-03-29" @default.
• W2792922144 creator A5009356306 @default.
• W2792922144 creator A5016971686 @default.
• W2792922144 creator A5023716783 @default.
• W2792922144 creator A5030573154 @default.
• W2792922144 creator A5036644187 @default.
• W2792922144 creator A5037079640 @default.
• W2792922144 creator A5055480338 @default.
• W2792922144 creator A5062381776 @default.
• W2792922144 creator A5063454515 @default.
• W2792922144 creator A5075557798 @default.
• W2792922144 creator A5085761036 @default.
• W2792922144 date "2018-01-01" @default.
• W2792922144 modified "2023-10-01" @default.
• W2792922144 title "Acceptance of Adjuvant and Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer in Germany: A Survey of Current Practice" @default.
• W2792922144 cites W1538189929 @default.
• W2792922144 cites W1757407923 @default.
• W2792922144 cites W1899700999 @default.
• W2792922144 cites W1974722941 @default.
• W2792922144 cites W1975246887 @default.
• W2792922144 cites W1975918912 @default.
• W2792922144 cites W2013578576 @default.
• W2792922144 cites W2026395165 @default.
• W2792922144 cites W2044542626 @default.
• W2792922144 cites W2044665836 @default.
• W2792922144 cites W2068100145 @default.
• W2792922144 cites W2072065123 @default.
• W2792922144 cites W2073804272 @default.
• W2792922144 cites W2077060392 @default.
• W2792922144 cites W2083847009 @default.
• W2792922144 cites W2106617114 @default.
• W2792922144 cites W2120322713 @default.
• W2792922144 cites W2120536962 @default.
• W2792922144 cites W2122063636 @default.
• W2792922144 cites W2126069168 @default.
• W2792922144 cites W2128042367 @default.
• W2792922144 cites W2137616140 @default.
• W2792922144 cites W2137937825 @default.
• W2792922144 cites W2147652977 @default.
• W2792922144 cites W2151278059 @default.
• W2792922144 cites W2160379180 @default.
• W2792922144 cites W2169709372 @default.
• W2792922144 cites W2462649057 @default.
• W2792922144 cites W2463498486 @default.
• W2792922144 cites W2473053524 @default.
• W2792922144 cites W2555968680 @default.
• W2792922144 cites W2756189317 @default.
• W2792922144 cites W4255496950 @default.
• W2792922144 doi "https://doi.org/10.1159/000487405" @default.
• W2792922144 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29510388" @default.
• W2792922144 hasPublicationYear "2018" @default.
• W2792922144 type Work @default.
• W2792922144 sameAs 2792922144 @default.
• W2792922144 citedByCount "9" @default.
• W2792922144 countsByYear W27929221442018 @default.
• W2792922144 countsByYear W27929221442019 @default.
• W2792922144 countsByYear W27929221442020 @default.
• W2792922144 countsByYear W27929221442021 @default.
• W2792922144 countsByYear W27929221442022 @default.
• W2792922144 crossrefType "journal-article" @default.
• W2792922144 hasAuthorship W2792922144A5009356306 @default.
• W2792922144 hasAuthorship W2792922144A5016971686 @default.
• W2792922144 hasAuthorship W2792922144A5023716783 @default.
• W2792922144 hasAuthorship W2792922144A5030573154 @default.
• W2792922144 hasAuthorship W2792922144A5036644187 @default.
• W2792922144 hasAuthorship W2792922144A5037079640 @default.
• W2792922144 hasAuthorship W2792922144A5055480338 @default.
• W2792922144 hasAuthorship W2792922144A5062381776 @default.
• W2792922144 hasAuthorship W2792922144A5063454515 @default.
• W2792922144 hasAuthorship W2792922144A5075557798 @default.
• W2792922144 hasAuthorship W2792922144A5085761036 @default.
• W2792922144 hasConcept C121608353 @default.
• W2792922144 hasConcept C126322002 @default.
• W2792922144 hasConcept C126894567 @default.
• W2792922144 hasConcept C143998085 @default.
• W2792922144 hasConcept C154775046 @default.
• W2792922144 hasConcept C166957645 @default.
• W2792922144 hasConcept C2775910329 @default.
• W2792922144 hasConcept C2776694085 @default.
• W2792922144 hasConcept C2778239845 @default.
• W2792922144 hasConcept C2780258809 @default.
• W2792922144 hasConcept C2780352672 @default.
• W2792922144 hasConcept C2781413609 @default.
• W2792922144 hasConcept C2781451048 @default.
• W2792922144 hasConcept C61434518 @default.
• W2792922144 hasConcept C71924100 @default.
• W2792922144 hasConcept C95457728 @default.
• W2792922144 hasConceptScore W2792922144C121608353 @default.
• W2792922144 hasConceptScore W2792922144C126322002 @default.
• W2792922144 hasConceptScore W2792922144C126894567 @default.
• W2792922144 hasConceptScore W2792922144C143998085 @default.
• W2792922144 hasConceptScore W2792922144C154775046 @default.
• W2792922144 hasConceptScore W2792922144C166957645 @default.
• W2792922144 hasConceptScore W2792922144C2775910329 @default.
• W2792922144 hasConceptScore W2792922144C2776694085 @default.
• W2792922144 hasConceptScore W2792922144C2778239845 @default.
• W2792922144 hasConceptScore W2792922144C2780258809 @default.
• W2792922144 hasConceptScore W2792922144C2780352672 @default.
• W2792922144 hasConceptScore W2792922144C2781413609 @default.

• next